Critical Care
(Aug 2020)
Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
- Hideta Nakamura,
- Takeshi Kinjo,
- Wakako Arakaki,
- Kazuya Miyagi,
- Masao Tateyama,
- Jiro Fujita
Affiliations
- Hideta Nakamura
- Department of Infectious, Respiratory and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus
- Takeshi Kinjo
- Department of Infectious, Respiratory and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus
- Wakako Arakaki
- Department of Infectious, Respiratory and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus
- Kazuya Miyagi
- Department of Infectious, Respiratory and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus
- Masao Tateyama
- Department of Infectious, Respiratory and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus
- Jiro Fujita
- Department of Infectious, Respiratory and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus
- DOI
-
https://doi.org/10.1186/s13054-020-03209-6
- Journal volume & issue
-
Vol. 24,
no. 1
pp.
1
– 3
WeChat QR code
